Propiedad y actividad de insiders de Acrivon Therapeutics, Inc. Common Stock (ACRV): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.70 |
| Capitalización | $73M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-31 | Levin Michaela | A-Award | 130,000 | $272K |
| 2026-08-31 | Levin Michaela | A-Award | 30,000 | |
| 2026-08-31 | Levin Michaela | |||
| 2026-08-25 | Blume-Jensen Peter | S-Sale | 14,036 | $31K |
| 2026-08-18 | Peterson Katharine | S-Sale | 101 | $203 |
| 2026-08-18 | Miller Mary | S-Sale | 185 | $372 |
| 2026-08-18 | Gamelin Erick | S-Sale | 400 | $804 |
| 2026-08-18 | Devroe Eric | S-Sale | 604 | $1K |
| 2026-08-18 | Blume-Jensen Peter | S-Sale | 1,229 | $2K |
| 2026-08-18 | Blume-Jensen Peter | S-Sale | 484 | $973 |
Balance (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Caja y Equivalentes | $1.6M | $99.6M | $29.5M | $36.0M | $39.8M | $41.5M |
| Inversiones a Corto | 0 | 0 | $98.2M | $91.4M | $139.7M | $77.1M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.7M | $100.4M | $132.1M | $129.7M | $181.6M | $120.4M |
| Inmovilizado Material | $59000 | $5.8M | $6.9M | $7.9M | $8.0M | $7.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $2.2M | $106.6M | $181.2M | $138.3M | $196.6M | $129.7M |
| Cuentas por Pagar | $136000 | $964000 | $904000 | $5.0M | $758000 | $2.3M |
| Deuda a Corto | $58000 | 0 | 0 | 0 | $1.1M | 0 |
| Pasivos Corrientes | $613000 | $2.9M | $6.5M | $13.3M | $17.2M | $15.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $10.6M | $130.4M | $10.8M | $17.1M | $19.8M | $17.2M |
| Reservas | -$8.6M | -$24.9M | -$56.0M | -$116.4M | -$197.0M | -$274.9M |
| Patrimonio Neto | -$8.4M | -$23.8M | $170.5M | $121.2M | $176.8M | $112.5M |
| Deuda Total | $58000 | $5.6M | $5.0M | $4.6M | $3.6M | $2.7M |
| Deuda Neta | -$1.5M | -$94.0M | -$122.8M | -$122.8M | -$175.8M | -$115.9M |
| Capital Circulante | $1.1M | $97.5M | $125.6M | $116.4M | $164.4M | $104.8M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 7.99 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -0.90 |
Rentabilidad
| Rentabilidad sobre capital | -70.14% |
| Rentabilidad sobre capital invertido | -88.28% |
| Rentabilidad sobre activos | -74.91% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ATYR · BMEA · CBUS · IMUX · PMVP · RLMD · RPTX
Explorar sector: Healthcare · Biotechnology
Más secciones de ACRV: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones